Global Initiative for Asthma (GINA) guidelines: 15 years of application

Expert Review of Clinical Immunology

Volumn 5, Issue 3, 2009, Pages 239-249

  Kroegel, Claus ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Asthma control; Asthma guideline; Asthma management and prevention; Asthma severity; GINA; Global Initiative for Asthma; Paradigm shift in asthma

Indexed keywords

ACLIDINIUM BROMIDE; ARFORMOTEROL; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CARMOTEROL; CHOLINERGIC RECEPTOR BLOCKING AGENT; GLYCOPYRRONIUM BROMIDE; INDACATEROL; MUSCARINIC RECEPTOR BLOCKING AGENT; OMALIZUMAB;

ASTHMA; DISEASE CLASSIFICATION; DISEASE SEVERITY; EVIDENCE BASED PRACTICE; HUMAN; PATIENT EDUCATION; PRACTICE GUIDELINE; REVIEW; SELF CARE;

EID: 67649335786     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/eci.09.1     Document Type: Review

References (62)

1. National Asthma Education and Prevention Program, National Heart, Lung and Blood Institute, National Institutes of Health. Asthma Expert Panel Report 2. Guidelines for the Diagnosis and Management of Asthma. National Institutes of Health, Publication No. 97-4051. Bethesda, MD, USA (1997).
2. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma. National Institutes of Health, Publication No. 91-3642. Bethesda, MD, USA (1991).
3. National Heart, Lung and Blood Institute. International Consensus Report on Diagnosis and Management of Asthma. National Institutes of Health, Publication No. 92-3091. Bethesda, MD, USA (1992).
4. National Heart, Lung, and Blood Institute and World Health Organization. Global Initiative for Asthma. National Institutes of Health. Publication No. 95-3659. Bethesda, MD, USA (1995).
5. National Asthma Education and Prevention Program, National Heart, Lung and Blood Institute, National Institutes of Health. Asthma Expert Panel Report 3. Guidelines for the Diagnosis and Management of Asthma. National Institutes of Health, Publication No. 08-5846, Bethesda, MD, USA (2007).
6. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA dissemination committee report. Allergy 59, 469-478 (2004).
7. Fischer GB, Camargos PA, Mocelin HT. The burden of asthma in children: a Latin American perspective. Paediatr. Respir. Rev. 6, 8-13 (2005).
8. Price D, Ryan D, Pearce L et al. The burden of paediatric asthma is higher than health professionals think: results from the Asthma In Real life (AIR) study. Prim. Care Respir. J. 11, 30-33 (2002).
9. Bateman ED, Boushey HA, Bousquet J et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study. Am. J. Resp. Crit. Care Med. 170, 836-844 (2004).
10. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur. Respir. J. 16, 802-807 (2000).
11. Sawyer G, Miles J, Lewis S, Fitzharris P, Pearce N, Beasley R. Classification of asthma severity: should the international guidelines be changed? Clin. Exp. Allergy 28, 1565-1570 (1998).
12. Myers TR. Guidelines for asthma management: a review and comparison of 5 current guidelines. Respir. Care 53, 751-769 (2008).
13. Guarnaccia S, Lombardi A, Gaffurini A et al. Application and implementation of the GINA asthma guidelines by specialist and primary care physicians: a longitudinal follow-up study on 264 children. Prim. Care Respir. J. 16, 357-362 (2007).
14. Moth G, Schiotz PO, Vedsted P. A Danish population-based cohort study of newly diagnosed asthmatic children's care pathway - adherence to guidelines. BMC Health Serv. Res. 8, 130 (2008).
15. Bousquet J, Clark TJ, Hurd S et al. GINA guidelines on asthma and beyond. Allergy 62, 102-112 (2007).
16. Crofton J, Douglas A. Respiratory Diseases (3rd Edition). Blackwell Scientific, London, UK (1981).
17. Sears MR, Rea HH, Fenwick J et al. Deaths from asthma in New Zealand. Arch. Dis. Child. 61, 6-10 (1986).
18. Peat JK, van den Berg RH, Green WF, Mellis CM, Leeder SR, Woolcock AJ. Changing prevalence of asthma in Australian children. BMJ 308(6944), 1591-15916 (1994).
19. Pearce N, Beasley R, Crane J, Burgess C, Jackson R. End of the New Zealand asthma mortality epidemic. Lancet 345(8941), 41-44 (1995).
20. Kay AB. Allergy and allergic diseases. First of two parts. N. Engl. J. Med. 344, 30-37 (2001).
21. Kroegel C, Matthys H. Bronchiale Asthma. In: Clinial Pneumology (2nd Edition). Matthys H, Seeger W (Eds). Springer, NY, USA 229-298 (2008).
22. Guidelines for management of asthma in adults: I - Chronic persistent asthma. Statement by the British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign. Published erratum appears in BMJ 301(6757), 924 (1990).
23. British Thoracic Society, Royal College of Physicians of London, King's Fund Centre et al. Guidelines for the management of asthma in adults: I - chronic persistent asthma. BMJ 301, 651-653 (1990).
24. British Thoracic Society, Royal College of Physicians of London, King's Fund Centre et al. Guidelines for the management of asthma in adults: II - acute severe asthma. BMJ 301, 797-800 (1990).
25. British Thoracic Society, British Paediatric Association, Royal College of Physicians of London et al. Guidelines on the management of asthma. Thorax 48(Suppl. 2), S1-24 (1993).
26. British Thoracic Society, National Asthma Campaign, Royal College of Physicians of London et al. The British guidelines on asthma management: 1995 review and position statement. Thorax 52(Suppl. 1), S1-21 (1997).
27. Li JT, Pearlman DS, Nicklas RA et al. Algorithm for the diagnosis and management of asthma: a practice parameter update: Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. Ann. Allergy Asthma Immunol. 81(5 Pt 1), 415-420 (1998).
28. British Thoracic Society (BTS) and Scottish Intercollegiate Guidelines Network. British guidelines on the management of asthma. Thorax 58(Suppl. 1), 1-99 (2003).
29. Becker A, Lemière C, Bérubé D et al; on behalf of The Asthma Guidelines Working Group of the Canadian Network For Asthma Care. Summary of recommendations from the Canadian Asthma Consensus Guidelines, 2003. CMAJ 173(Suppl. 6), S1-S55 (2005).
30. Boulet LP, Becker A, Bérubé D, Beveridge R, Ernst P. Canadian asthma consensus report, 1999. CMAJ 161(Suppl. 11), S1-62 (1999).
31. Ernst P, Fitzgerald J, Spier S. Canadian Asthma Consensus Conference: summary of recommendations. Can. Respir. J. 3, 89-100 (1996).
32. Neville RG, Higgins BG. Issues at the interface between primary and secondary care in the management of common respiratory disease. 3: providing better asthma care: what is there left to do? Thorax 54, 813-817 (1999).
33. Van-den-Molen T, Ostrem O, Stallberg B, Stubbe-Ostergaard M, Singh R. International Primary Care Respiratory Group (IPCRG) Guidelines: management of asthma. Prim. Care Respir. J. 15, 35-47 (2006).
34. Price D, Bond C, Bouchard J et al. International Primary Care Respiratory Group (IPCRG) guidelines: management of allergic rhinitis. Prim. Care Resp. J. 15, 58-70 (2006). (Pubitemid 43155767)
35. Guyatt GH, Oxman AD, Kunz R et al.; GRADE Working Group. Going from evidence to recommendations. BMJ 336, 1049-1051 (2008).
36. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 328, 1490-1498 (2004).
37. Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Developing guidelines. BMJ 318, 593-596 (1999).
38. Barton S. Which clinical studies provide the best evidence? The best RCT still trumps the best observational study. BMJ 321, 255-256 (2000).
39. Mant D. Can randomized trials inform clinical decisions about individual patients? Lancet 353, 743-746 (1999).
40. Earle CC, Weeks JC. Evidence-based medicine: a cup half full or half empty? Am. J. Med. 106,263-264 (1999).
41. Cockcroft DW, Swystun VA. Asthma control versus asthma severity. J. Allergy Clin. Immunol. 98(6 Pt 1), 1016-1018 (1996).
42. Zervas E, Oikonomidou E, Kainis E, Kokkala M, Petroheilou K, Gaga M. Control of asthma. Ther. Adv. Respir. Dis. 2, 141-148 (2008)
43. Kroegel C. Asthma control as the basis for asthma treatment. Global Initiative for Asthma prevention - GINA 2006. Pneumology 61, 295-304 (2007).
44. Yawn BP, Brenneman SK, Allen-Ramey FC, Cabana MD, Markson LE. Assessment of asthma severity and asthma control in children. Pediatrics 118, 322-329 (2006).
45. Boulet LP, Bai T, Becker A et al. What is new since the last (1999) Canadian Asthma Consensus Guidelines? Can. Respir. J. 8(Suppl. A), A5-A27 (2001).
46. Roche N, Morel H, Martel P, Godard P. Clinical practice guidelines: medical follow-up of patients with asthma - adults and adolescents. Respir. Med. 99, 793-815 (2005).
47. Li J, Oppenheimer J, Bernstein I, Nicklas R. Attaining optimal asthma control: a practice parameter. J. Allergy Clin. Immunol. 116, S3-S11 (2005).
48. Oppenheimer JJ, Li J. Attaining asthma control. Curr. Opin. Allergy Clin. Immunol. 6, 119-123 (2006).
49. Schatz M, Mosen D, Apter AJ et al. Relationships among quality of life, severity, and control measures in asthma: an evaluation using factor analysis. J. Allergy Clin. Immunol. 115, 1049-1055 (2005).
50. Bateman ED. Measuring asthma control. Curr. Opin. Allergy Clin. Immunol. 1, 211-216 (2001).
51. Colice G. Categorizing asthma severity: an overview of national guidelines. Clin. Med. Res. 2, 155-163 (2004).
52. Taylor DR, Bateman ED, Boulet LP et al. A new perspective on concepts of asthma severity and control. Eur. Respir. J. 32, 545-554 (2008).
53. Bateman ED. Severity and control of severe asthma. J. Allergy Clin. Immunol. 117, 519-521 (2006).
54. Kroegel C, Bergmann N, Foerster M et al. Interferon-acon-1 treatment of three patients with severe glucocorticoiddependent asthma. Effect on disease control and systemic glucocorticosteroid dose. Respiration 73, 566-570 (2006).
55. Kroegel C, Foerster M. Omalizumab. In: Handbook of Therapeutic Antibodies (Volume III). Dübel S (Ed.). Wiley-VCH, Weinheim, Germany 951-997 (2007).
56. Nopp A, Johansson SG, Ankerst J, Palmqvist M, Oman H. CD-sens and clinical changes during withdrawal of Xolair after 6 years of treatment. Allergy 62, 1175-1181 (2007).
57. Tatsis E, Schnabel A, Gross WL. Interferon-a treatment of four patients with the Churg-Strauss syndrome. Ann. Intern. Med. 129(5), 370-374 (1998).
58. WHO. Asthma: facts about asthma www.who.int/mediacentre/factsheets/fs307/ en/index.html
59. British Guideline on the Management of Asthma. Guideline No. 101 (ISBN 978190581285) www.sign.ac.uk/guidelines/fulltext/101/index.html
60. International Primary Care Airways Group (IPAG). Chronic airways diseases. A guide for primary care physicians http://www.ipagguide.org/IPAG- copyright-draft.pdf
61. Global Initiative for Asthma (GINA). 2006 revision www.ginasthma.com
62. Workshop Report, Global Strategy for Asthma Management and Prevention www.ginasthma.com